A new analysis released by the Kaiser Family Foundation?s Commission on Medicaid and the Uninsured provides an overview of online applications for Medicaid and/or Children's Health Insurance Program (CHIP).
The June 2011 Commonwealth Fund issue brief, “Assessing the Financial Health of Medicaid Managed Care Plans and the Quality of Patient Care They Provide,” examines how publicly traded health plans differ from non–publicly traded ones in terms of administrative expenses, quality of care, and financial stability.
It found publicly traded plans that focused primarily on Medicaid enrollees paid out the lowest percentage of their Medicaid premium revenues in medical expenses and reported the highest percentage in administrative expenses across different types of health plans. The publicly traded plans also received lower scores for quality-of-care measures related to preventive care, treatment of chronic conditions, members’ access to care, and customer service.
The study “used limited data to draw inappropriate conclusions regarding the Medicaid health plan industry,” according to a press statement issued by the Medicaid Health Plans of America (MHPA), the trade group representing the industry.
In the statement, MPHA says the results suggest that a relationship exists between ownership status and quality of care and costs, when it is, “impossible to accurately draw such conclusions given the large amount of missing and incomplete data in the study.”
MPHA claims inadequate sample size, under-representation of certain types of companies, and access to financial data from only three-quarters of the plans identified as meeting the criteria for the study as shortcomings.
“Far worse is that the authors had preventive and chronic condition data from only one-third of the plans (with certain types of plans over- and under-represented), yet still opted to draw universal conclusions about ownership status and quality of care,” according to the MPHA press statement.
The Commwealth Fund issue brief itself points out the study’s limitations and lists its data collection methodology.
“Overall, this analysis has several limitations,” the brief concludes, going on to list five potential problems with the analysis:
1. The number of observations within selected traits was small, especially for quality-of-care measures.
2. Publicly traded plans were underrepresented among the health plans reporting quality measures to the National Committee for Quality Assurance (NCQA) relative to their prevalence.
3. The descriptive statistical approach of the median tests assesses the financial and quality-of-care measures in isolation of the plan trait and does not control for market and policy factors that may influence the variation of these measures.
4. Health plans in Arizona and California do not follow National Association of Insurance Commissioners (NAIC) statutory financial reporting guidelines, but instead follow Statement of Financial Accounting Standards. “The reporting of administrative costs may have been affected by these different accounting standards as well as the allocation of these costs by plans owned by parent companies,” the report states.
5. Regional variation may also influence the outcome of the financial and quality-of-care measures.
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Listen
35th World AIDS Day Marks 20 Years of PEPFAR: Challenges and Strategies to Combat HIV/AIDS
November 29th 2023PEPFAR, having invested $100 billion and saved 25 million lives in the global fight against HIV/AIDS, faces Congressional hurdles in its reauthorization due to abortion debates. Despite widespread support and no evidence of abortion-related activities, the legislative process is at a standstill. Members of PEPFAR and authors of a recent editorial stress the significance of PEPFAR and advocate for integrating behavioral and social science into healthcare programs to achieve UNAIDS targets and address barriers in HIV/AIDS testing and treatment.
Read More